The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Evidence in Practice

Thursday, 02 February 2017
A French observational study has found that use of a beta-blocker early after myocardial infarction (MI) (within 48 hours) is associated with a substantial reduction in 30-day mortality in people who do not have heart failure. However, continuing with beta-blockers was not associated with a significant reduction in mortality at 1 year.
Thursday, 02 February 2017
Offering smokers a taster session at an NHS Stop Smoking Service and explaining their personal risk of developing smoking-related diseases doubles their likelihood of attending a stop smoking course.
Thursday, 02 February 2017
Liraglutide 1.2 mg has proved cost-effective when compared to alternative daily administered GLP-1 receptor agonists for the treatment of type 2 diabetes in the UK.
Topics covered:
Thursday, 02 February 2017
A new study shows that increased activity in the amygdala (the part of the brain involved in stress) is associated with a greater risk of heart disease and stroke. This study provides new insights into the possible mechanism by which stress can lead to cardiovascular disease in humans.
Topics covered:
Wednesday, 04 January 2017
A new study suggests that a ‘Sit Less’ intervention ‒ breaking sitting with standing and light-intensity walking ‒ may be an alternative to structured exercise to promote blood sugar control in patients with type 2 diabetes, giving improved 24-hour glucose levels and improved insulin sensitivity.
Topics covered:
Wednesday, 04 January 2017
Adding evolocumab to optimised statin therapy results in statistically significant regression of atherosclerosis in patients with coronary artery disease, according to results from the GLAGOV phase 3 trial.
Topics covered:
Wednesday, 04 January 2017
Tackling obesity by offering the opportunity to attend a weight loss programme during a routine consultation is effective, welcomed by patients and takes only 30 seconds, according to a new randomised trial of over 1800 people in the UK.
Topics covered:
Thursday, 27 October 2016
Targeting cardiovascular disease risk factors may be important across a person’s lifetime, as a new study from the US National Institutes of Health shows that efforts to prevent risk factors should extend to those over 65 years of age.
Topics covered:

Article search and filter